Mount Sinai Cardiovascular Doctors to Receive Honors During American College of Cardiology 70th Annual Scientific Session
Two of Mount Sinai’s top cardiovascular physicians will be recognized for their achievements at the American College of Cardiology’s 70th Annual Scientific Session, taking place virtually from Saturday, May 15, through Monday, May 17.
William Whang, MD, Associate Professor of Medicine (Cardiology), and Gilbert Tang, MD, MSc, MBA, Associate Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, are receiving the 2021 Simon Dack Awards for their exceptional contributions to the Journal of the American College of Cardiology (JACC) for their peer reviews. This journal ranks among the top cardiovascular journals in the world for its scientific impact.
The Simon Dack Award is named for the founding editor of JACC and recognizes outstanding peer reviewers who assist the journal in its mission of publishing important new clinical information. Dr. Whang and Dr. Tang are among five physicians to earn this distinguished honor for 2021.
“I am grateful to contribute to such an important journal as JACC and appreciate the opportunity to learn from the high-quality exciting research that is so often submitted,” says Dr. Whang.
“It was a pleasant surprise and is a true honor to be recognized for my participation with JACC and the American College of Cardiology on their academic mission,” says Dr. Tang.
Dr. Whang is Director of Clinical Electrophysiology Research at The Mount Sinai Hospital. He is a practicing cardiac electrophysiologist who specializes in catheter ablation procedures and implantation of pacemakers/defibrillators and left atrial appendage closure devices. Dr. Whang has active research interests in catheter ablation and new device technologies for patients with cardiac arrhythmia. In 2020 he reviewed 19 manuscripts for JACC and its family of journals. He has published more than 100 manuscripts in journals including Circulation, JAMA, and JACC, as well as chapters in major cardiology textbooks including Hurst’s The Heart. He is a Fellow of the American Heart Association, the Heart Rhythm Society, and the New York Academy of Medicine.
Dr. Gilbert Tang is the Surgical Director of the Structural Heart Program for Mount Sinai and specializes in transcatheter valve interventions including transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (MitraClip), transcatheter mitral valve replacement (TMVR) and transcatheter tricuspid valve repair (TriClip). He pioneered a technique to help better orient a transcatheter heart valve during TAVR to make it easier to re-access the coronary arteries. Dr. Tang has active research interests in TAVR and transcatheter mitral and tricuspid valve therapies. In 2020, he reviewed nearly 20 manuscripts for JACC and its family of journals. He has published nearly 150 original research articles, invited letters and editorials, and review articles in top medical journals including JAMA, JACC, Circulation, JAMA Cardiology, JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, Circulation Cardiovascular Interventions, and has presented at many international conferences including ACC, AHA, TCT, TVT, EuroPCR, and PCR London Valves. He is currently involved in several multicenter studies with leading institutions in the United States and globally, including being the principal co-investigator in the international EXPLANT-TAVR and CUTTING-EDGE registries.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.